U

UroGen Pharma Ltd. (URGN)

NGM – Real Time Price. Currency in USD

47.84

+0.73 (1.55%)

Market open: Aug 12, 2026, 10:19 AM EDT

47.13

+0.02 (0.04%)

Previous after-hours: Aug 11, 2026, 7:36 PM EDT

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

UroGen Pharma Ltd. (URGN)

NGM – Real Time Price. Currency in USD

47.84

+0.73 (1.55%)

Market open: Aug 12, 2026, 10:19 AM EDT

47.13

+0.02 (0.04%)

Previous after-hours: Aug 11, 2026, 7:36 PM EDT

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

110M

90M

83M

64M

Cost of goods sold

-12M

-9M

-8M

Gross Profit

97M

82M

73M

57M

Operating expenses (excl. COGS)

-222M

-178M

-139M

-136M

Operating Income

-125M

-97M

-66M

-79M

Non-operating income, total

-29M

-27M

-33M

-29M

Pretax income

-153M

-124M

-98M

-108M

Equity in earnings

0

Taxes

-78K

-3M

-4M

-2M

Non-controlling/minority interest

0

After tax other income/expense

0

Net income before discontinued operations

-153M

-127M

-102M

-110M

Discontinued operations

0

Net income

-153M

-127M

-102M

-110M

Dilution adjustment

0

Preferred dividends

0

Search stocks

UroGen Pharma Ltd. (URGN)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

UroGen Pharma Ltd. (URGN)

Income Statement (Annual)